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Abstract 
Background: Retinopathy of prematurity (ROP) is the leading cause of blindness in 
newborn babies worldwide. The benefit of anti-oxidant was investigated for ROP cases 
by assessing its effect on the oxidative stress of the tissues. Glutathione is a primary 
endogenous in human body and its supplementation has been discovered for its 
benefits towards some ocular diseases.  
Objective: This study aims to understand the effect of glutathione on oxidative stress 
marker, serum Malondialdehyde (MDA), in ROP rat models. 
Methods This was an experimental study with posttest only controlled group design. 
Sixteen Wistar rats that met our study criteria were divided into two groups, study 
group and control group. The study group were exposed to 95% oxygen for 4 hours / 
day followed by normoxic laboratory condition for 20 hours. Glutathione 1.5 mg / day 
were injected intramuscularly to rats in study group. The control group was exposed 
to 95% oxygen followed by normoxic laboratory condition with the same manner, and 
did not received glutathione. This cycle was repeated for 14 days. Both groups were 
settled in a room temperature setting on days 15-22. Serum sample was collected from 
retroorbital vein. The malondialdehyde level was analyzed using MDA analyzer kit. 
Results MDA level was found significantly higher in study group compared to control 
group (546.99 ng/ml vs 201.51 ng/ml, respectively, p 0,001). 
Conclusion Our study demonstrated a higher MDA levels in ROP rat models given 
glutathione injection compared to the control group.  
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INTRODUCTION 
 Retinopathy of prematurity (ROP) is a 
developmental retinal vascular disorder that affects 
prematurely born infants. Retinopathy of prematurity is 
the leading cause of blindness in new born babies 
worldwide. Prematurity, low birth weight, blood 
transfusion, sepsis, intraventricular hemorrhage, blue 
light therapy, mechanical ventilation therapy, and 
administration of high-pressure oxygen are some 
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 Recent study has found that oxidative stress plays an 
important role in pathogenesis of ROP. Retina as one of 
body tissues that are sensitive to hypoxic and hiperoxic 
conditions will undergo oxidative stress due to high 
pressure oxygen exposure. This is characterized by 
imbalance of reactive oxygen species (ROS) and 
antioxidant levels in the body.2 Malondialdehyde (MDA) 
has been widely used as an oxidative stress biomarker.3-5 
MDA levels in body tissues can indicate the occurring 
stress oxidative stress degree.5 
 The antiperoxidative effects of some anti-oxidant 
agents such as vitamin E, vitamin A, Lutein, superoxide 
dismutase (SOD) have been studied in ROP cases with 
conflicting results. Some benefits and the harmful side 
effects of the anti-oxidant have been reported.6 Thus, 
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needed to be explored, particularly in ROP case. 
Glutathione (GSH) is the primary endogenous 
antioxidant in the body. Glutathione is formed naturally 
inside the body, but increased of free radicals production 
leads to inadequate availability of these antioxidant. 6-8  
Glutathione have been studied for some ocular disorders 
such as cataract and glaucoma.6,9 In this study 
investigated the effect of glutathione injection on MDA 
levels in rat models that exposed to high pressure oxygen 
(ROP rat models).  
 
MATERIALS AND METHODS 
 This was an experimental study with post test only 
controlled group design. Breeding and intervention of 
animal was performed in Biology Laboratory, Faculty of 
Mathematics and Sciences, Universitas Negeri 
Semarang. The sample was 16 Wistar rats (1-7 days old), 
weighed 10-20 grams. All Wistar rats were given 
standard feeding and suckled directly from the mother. 
Management and treatment of experimental animals in 
this study has been approved by the Ethics Health 
Research Commission, Faculty of Medicine, 
Diponegoro University/ Kariadi Central Public Hospital, 
Semarang (No. 10/EC/H/FK-UNDIP/II/2019) 
 
Hyperoxic exposure 
 A preliminary study was conducted to refine the 
hyperoxic exposure effect to the histological appearance 
of retina in rats. We found that the hyperoxic exposure 
induced higher amount of retinal neovascularization 
compare to the control group.10 In the current 
experiment, sixteen Wistar rats that met our study 
criteria were used. The rats were randomly divided into 
two groups, study group and control group. The study 
group rats were placed on animal box which 95% 
oxygen was continuously delivered at a flow rate 2.7 
liters/minute. Rats were exposed to this hyperoxic 
condition for 4 hours / day, followed by normoxic 
laboratory condition for 20 hours. The control group was 
exposed to 95% oxygen exposure with similar 
administration manner for 4 hours / day followed by 
normoxic laboratory condition for 20 hours. This cycle 
was repeated for 14 days. Both groups were settled in a 
room temperature setting on days 15-22. 
 
Glutathione supplementation 
 Glutathione 1.5 mg intramuscular / day were injected 
to rats in study group for 14 days.  
 
Serum sampling and MDA level Analysis 
 Serum sample was collected from retroorbital vein 
on day 23. The malondialdehyde level was analyzed 
using MDA analyser kit. MDA level analyzed using 
MDA analyzer kit and performed in GAKI Laboratory, 
Faculty of Medicine, Diponegoro University.  
 The obtained data were analyzed statistically using 
SPSS for windows version 19.0. Data normality test 
were done by Saphiro-Wilk test and the hypothesis was 
tested by unpaired T test. 
 
RESULTS 
 Sixteen Wistar rats in both groups were alive on day 
23 when the experiment terminated. The collected data 
was serum MDA level in both groups. Mean MDA level 
in control group was 201.51 ± 62.55 ng/ml, with 
minimum level 106.65 ng/ml and maximum level 326.60 
ng/ml. Mean MDA level in study group was 546.99 ± 
118.38 ng/ml, with minimum level 327.94 ng/ml and 
maximum level 707.92 ng/ml (Table 1).  
 All data were normally distributed based on statistical 
analysis using Saphiro wilk test. The analysis showed that 
MDA level of the study group was higher than control 
group, with p value 0.001 (Table 2) 
 
Table 1. MDA Level 
 
Table 2. Unpaired T test results 
 
DISCUSSION 
 Studies about glutathione’s protective effect on 
oxidative stress has been developed in several animal 
models such as myocardial injury, liver injury, renal 
ischemia, cataracts, and glaucoma animal models.9-14 
This study used oxygen induced retinopathy (OIR) 
methods to assess the effect of glutathione in ROP rat 
models. Our study revealed that serum MDA level of 
Wistar rats exposed to oxygen is higher than serum MDA 
level of healthy rats obtained from the literature data. 
Healthy Wistar MDA level was in the range 78.5-97.3 
nmol / mg while MDA level of ROP rat models in this 
study were in the range 106.44-327.81 nmol / mg.15 This 
is consistent with previous study that demonstrated an 
increase in MDA levels of retinopathy of prematurity 
babies. Premature babies has not ready to experience 
extra uterine life that contains high oxygen content. The 
use of high concentration oxygen therapy in premature 
babies worsen the oxidative stress that happened, 
characterized by increase of MDA level, both in serum 
and tissues. One of the tissues that experiencing 
developmental aberration due to complex oxidative stress 
process is retina.16-20 
 Analysis of this study showed MDA level in Wistar 
retinopathy of prematurity models injected with 
glutathione intramuscularly was higher than the control 
group (546.99 ng/ml vs 201.51 ng/ml, respectively). This 
result was contradicting to some of previous studies 
about glutathione. Study about injection of glutathione in 
renal ischemia animals revealed a lower MDA levels in 
the treatment group compare to the control group (25.40 
nm / mg protein vs 37.40 nm / mg, respectively).11 
Similarly to study about the effect of glutathione on rat 
with myocardial injury, obtained MDA levels in 
treatment group (0.6 nmol / mg) was lower than the 
control group (0.7 nmol/ mg).13 Our study result was also 
contradictive to study about another antioxidant, L-
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carnitine, that was tried out to ROP rat models. L-
carnitine has protective effect, characterized by decrease 
in MDA level from 24.44 nmol/mg to 13.86 nmol/mg.3 
 It has widely known that oxidative status in human 
body is affected by the balance between free radicals 
agent and antioxidant that counter back. Imbalance leads 
to progressive damage of cell structure. Antioxidant 
supplementation helps body defensive system to fight 
back free radicals, especially ROS. On the other hand, 
ROS in normal level is doing its function, cell signaling 
and regulating redox. Free radicals escalation in the 
moderate amount can stimulates body immunity system 
and have protective effects in the body.12 Studies 
suggested to calculate endogenous antioxidant level in 
the body before administer synthetic antioxidant 
supplementation. Thus, there would be no antioxidant 
level excess in the body than could lead to antioxidant 
imbalance. Previous study reported there are some 
synthetic antioxidant that can be contradictory, known as 
pro-oxidant. Pro-oxidant is a compound that stimulates 
oxidative process in the body through the formation of 
singlet oxygen.21 Some of the theories mentioned above 
might become explanations regarding the high level of 
oxidative stress markers in antioxidant supplementation 
in this study. The dose of glutathione used in this study 
was likely too high to be injected into baby rat, thereby 
stimulating the oxidant-antioxidant imbalance. To date, 
there is no preceding study suggesting about injecting 
glutathione to baby rat even it is safe to administer 
glutathione for a full-grown rat. We suggest further 
research with adjusted dosage of glutathione.  
 
CONCLUSION 
 Our study demonstrated a higher serum MDA levels 
in ROP rat models given glutathione injection compared 
to the control group. Further study about 
antiperoxidative effect with an adjusted dosage of 
glutathione are warranted 
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